Gary W. Herschman and Anjana D. Patel, Members of the Firm in the Health Care & Life Sciences practice, in the firm’s Newark office, were quoted in Bloomberg Health Law & Business News, in “Covid-19 Surges, Vaccines Drive Pharma, Device Deal Growth,” by Sara Hansard. Zachary S. Taylor, Associate in the Health Care & Life Sciences practice, serves with Mr. Herschman and Ms. Patel on Bloomberg Law’s Health Care Transactions Editorial Committee.
Following is an excerpt:
Pharma deals keep rising “as the race to immunize the planet continues while, at the same time, variants of the virus are discovered putting additional pressure on these companies to stay one step ahead,” Anjana Patel, a member of Epstein Becker Green in its Newark office, said. ...
Transactions in the medical device sector are also expected to climb in part due to Covid-19 vaccines like the one by Pfizer Inc. and BioNTech, Patel said, which must be stored in ultra-cold freezers.
Physician practices and services was one of the most active sectors, with 24 deals announced or completed in November and 183 year-to-date, Gary Herschman, a member of Epstein Becker Green in its Newark office, said.
“Notably, half of the deals consisted of primary care and urgent care practices,” Herschman said. “We expect this surge to continue even faster in 2021.”
Hospital and health system transactions were in the single digits in November (9) and totaled only 99 year-to-date, “which is unsurprising given the continued focus on management of the pandemic,” Herschman said. ...
